C2 C Wealth Management, LLC Nova Bay Pharmaceuticals, Inc. Transaction History

C2 C Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 12, 2022	SELL	$0.11 - $147.37 $5,398 - $7.23 Million	-49,080 Reduced 71.05%	20,000 $2,000
Q2 2022 Jul 22, 2022	SELL	$0.18 - $0.31 $165 - $285	-920 Reduced 1.31%	69,080 $17,000
Q1 2022 Apr 29, 2022	BUY	$0.27 - $0.4 $5,130 - $7,600	19,000 Added 37.25%	70,000 $17,000
Q4 2021 Feb 23, 2022	BUY	$0.38 - $0.61 $19,380 - $31,110	51,000 New	51,000 $19,000

2.94K

Ticker NBY
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,988,400
Market Cap $42.2M
Description
NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and Phase...

Get notified when there are updates to the investment portfolio of C2 C Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on C2 C Wealth Management, LLC with notifications on news.